Innovation to Impact: Drug Development, AI, and Regulatory Strategy

The Danger of Data You Can’t Interpret

More data sounds good until it starts making everyone anxious, confused, or falsely confident. In this conversation, Brian Berridge, Nick Kelley, and Szczepan Baran expl

De-Risking What Matters

In this episode of Innovation to Impact: Ruminations & Ramblings, Szczepan Baran, Brian Berridge, and Nick Kelley tackle one of the biggest problems in modern drug develo

Innovation That Earns Deletion (Subtractive Trust)

Click here to watch a video of this episode. Drug development workflows only get heavier, and subtractive change requires predictivity and decision-grade evidence that c

Biology, Loops, and Decision-Grade Trust

Click here to watch a video of this episode. In drug development, go/no-go decisions concentrate translational risk and expose real consequences. When AI or digital biom

Rethinking Return in Drug Development

Click here to watch a video of this episode. In drug development, ROI debates can drown out decision-grade evidence and the hard work of translational science. This epis

Predictivity Is the New Currency of Drug Development

Click here to watch a video of this episode. Drug development punishes optimism, and predictivity is one of the few defenses we have against translational risk. In this

Patients First. Platforms Second

Click here to watch a video of this episode. In drug development, translational science can generate endless options, but decision-grade evidence starts with the patient